AEON Biopharma Inc.
(AEON)
undefined
undefined%
At close: undefined
0.19
1.66%
After-hours Jan 08, 2025, 08:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 5.16M | 9.75M | 5.13M | 20.17M | 6.32M |
| Short-Term Investments | n/a | n/a | n/a | n/a | 105.42M |
| Long-Term Investments | n/a | n/a | n/a | n/a | 1.43M |
| Other Long-Term Assets | 29.00K | 34.00K | 360.00K | 838.00K | 778.00K |
| Receivables | n/a | n/a | n/a | n/a | 267.00K |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.06M | 92.00K | 26.00K | 208.00K | 133.00K |
| Total Current Assets | 6.22M | 9.84M | 5.15M | 20.38M | 112.14M |
| Property-Plant & Equipment | 594.00K | 906.00K | 922.00K | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 623.00K | 940.00K | 1.28M | 838.00K | 2.21M |
| Total Assets | 6.84M | 10.78M | 6.44M | 21.21M | 114.35M |
| Account Payables | 3.39M | 7.80M | 1.19M | 2.03M | 1.02M |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 278.00K | 71.12M | 15.60M | n/a | 14.79M |
| Other Current Liabilities | 8.81M | 3.65M | 4.01M | 2.17M | 1.68M |
| Total Current Liabilities | 13.05M | 82.57M | 20.80M | 4.20M | 17.50M |
| Long-Term Debt | n/a | 60.67M | 71.29M | 72.16M | 15.16M |
| Other Long-Term Liabilities | 146.84M | 137.95M | 138.17M | 148.09M | 147.56M |
| Total Long-Term Liabilities | 146.84M | 198.62M | 209.46M | 220.25M | 162.73M |
| Total Liabilities | 159.89M | 281.19M | 230.26M | 224.45M | 180.22M |
| Total Debt | 278.00K | 131.53M | 86.89M | 72.16M | 29.95M |
| Common Stock | 4.00K | 14.00K | 14.00K | 11.00K | 11.00K |
| Retained Earnings | -473.60M | -474.84M | -422.28M | -366.65M | -333.73M |
| Comprehensive Income | n/a | n/a | n/a | n/a | n/a |
| Shareholders Equity | -153.04M | -287.50M | -234.94M | -208.27M | -67.15M |
| Total Investments | n/a | n/a | n/a | n/a | 106.85M |